Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications
about
Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancerSubstrate preference is altered by mutations in the fifth transmembrane domain of Ptr2p, the di/tri-peptide transporter of Saccharomyces cerevisiae.Bidirectional electrogenic transport of peptides by the proton-coupled carrier PEPT1 in Xenopus laevis oocytes: its asymmetry and symmetryThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues.Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung.Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1.An update on renal peptide transporters.Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.Cytosolic COOH terminus of the peptide transporter PEPT2 is involved in apical membrane localization of the protein.Hypothyroidism induces expression of the peptide transporter PEPT2.High-affinity peptide transporter PEPT2 (SLC15A2) of the zebrafish Danio rerio: functional properties, genomic organization, and expression analysis.Iron and porphyrin trafficking in heme biogenesis.Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.Comparison of Growth Performance and Whole-body Amino Acid Composition in Red Seabream (Pagrus major) Fed Free or Dipeptide Form of Phenylalanine.The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.AtGAT1, a high affinity transporter for gamma-aminobutyric acid in Arabidopsis thalianaMechanisms and clinical implications of renal drug excretion.Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.The housekeeping dipeptide permease is the Escherichia coli heme transporter and functions with two optional peptide binding proteins.Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected].Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid.Overexpression of membrane proteins from higher eukaryotes in yeasts.Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes.Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters.Mechanistic studies on delta-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line.The proton-coupled oligopeptide transporter 1 plays a major role in the intestinal permeability and absorption of 5-aminolevulinic acidFunctional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and humanMinimal molecular determinants of substrates for recognition by the intestinal peptide transporter.Pharmaceutical and pharmacological importance of peptide transporters.Evolution of an amino acid based prodrug approach: stay tuned.Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice.Role and relevance of PEPT2 in drug disposition, dynamics, and toxicityUrea nitrogen salvage mechanisms and their relevance to ruminants, non-ruminants and man.Derivatives of 5-aminolevulinic Acid for photodynamic therapy.
P2860
Q26798303-8E0E8050-6C0C-4CCD-BE05-40122BA07223Q27930126-95C6B228-7BED-4654-9928-0686B89B1F33Q28361689-9BCA45A3-CF73-4D65-B423-405A777D31CCQ30486743-AC4889F6-9ACE-465A-862F-F52C51A831C8Q31032411-FF9CF33F-9207-4DFA-88E0-F230AE62B2A2Q33181593-4D6B1C10-14CB-4325-A335-AD163EC1962DQ33183310-2E7EB477-A14E-481E-B0F8-571EEEA7D99FQ33183564-8E04996D-9668-41DC-B241-B1FB7B87BC5FQ33183818-6CA691ED-B711-4A0F-9071-AA61AC79CBBCQ33186616-0D19E57B-A74A-4951-964C-C459B5B48799Q33198362-F683EE09-E14F-427B-AABC-027E42824101Q33221888-C186BAA4-BFB4-4DAD-96C9-9A0D91C0AB58Q33224482-577D0789-2FA7-42A5-BEDC-CA0BACCEE069Q33228147-2A14A434-8466-4B5A-98E1-294B0BEBB634Q33349194-5F8AA700-1D03-4A72-82CA-5DBEFD1D24E0Q33412105-915D7EEB-8AEA-42CD-8E22-B38383A223B8Q33714593-EA04F9EC-BCC1-4120-B270-0706128EABE5Q33739471-26A0E967-C8E0-4F12-BCEF-B7E2B72461E4Q33884345-429415C1-969A-42A1-A17A-2ADF43C00F05Q34342258-7367BF6B-C940-40E5-A824-FF6D83F5418AQ34437543-9ABBDF37-61A2-41FD-8782-CF1F67BFDA2EQ34479011-9E26F451-A08D-40DA-B43C-CAE35AC91BFCQ34981676-CF994EE2-C5D7-458E-B46A-EE1EFB58B320Q35036520-7437E526-BFCF-47D2-9D17-E6CCFAB1F1D2Q35122097-9B012578-FB84-4A73-9DF5-82B7E5568FC5Q35159084-BAC8F349-3832-4BBE-BF71-AA08B5D51293Q35214601-986B2893-5107-47A0-B416-087C6DC4C56CQ35545774-AEC15580-F3F8-416D-9F05-5D65BDCF3B12Q35691207-9172346C-D1BE-4963-86AD-BBCA6FB374CEQ36645968-8C73D890-9E36-4CD4-831D-396AF73BE689Q36670762-AF54B401-90EB-447D-A29E-F614D2178FD0Q36744197-B7C252B0-09B5-42D8-8F28-07042AC927CEQ36787691-C7DC710B-529E-4CA7-8305-78DD2AF6C68FQ36898272-C093DC70-8AE4-4C8F-A419-9141EA805113Q37139860-1DD6197E-736F-429C-95F9-33329A30EAFCQ37210087-3B1AA718-8151-4747-A761-C90BBFCE6D4AQ37233001-2F9CDA2B-BA2D-4584-9A1C-ECC2FC6B7D24Q37258172-6B67B7DF-7C83-483C-9168-777FB2605B9FQ37350037-02B6CDA0-AC13-4BBD-B03A-5823B93580A4Q37369850-2A2F59C2-C154-4A41-9B7D-812789E02C64
P2860
Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Delta-aminolevulinic acid tran ...... ical and clinical implications
@ast
Delta-aminolevulinic acid tran ...... ical and clinical implications
@en
Delta-aminolevulinic acid tran ...... ical and clinical implications
@nl
type
label
Delta-aminolevulinic acid tran ...... ical and clinical implications
@ast
Delta-aminolevulinic acid tran ...... ical and clinical implications
@en
Delta-aminolevulinic acid tran ...... ical and clinical implications
@nl
prefLabel
Delta-aminolevulinic acid tran ...... ical and clinical implications
@ast
Delta-aminolevulinic acid tran ...... ical and clinical implications
@en
Delta-aminolevulinic acid tran ...... ical and clinical implications
@nl
P2093
P2860
P356
P1476
Delta-aminolevulinic acid tran ...... ical and clinical implications
@en
P2093
P2860
P304
P356
10.1172/JCI1909
P407
P577
1998-06-15T00:00:00Z